Citation: | LI Shidong, LV Rui, JIN Xin. Efficacy and safety of paclitaxel concomitant with Tegafur Gimeracil Oteracil Potassium Capsule in the treatment of patients with advanced gastric carcinoma[J]. Journal of Clinical Medicine in Practice, 2014, (13): 113-115. DOI: 10.7619/jcmp.201413038 |
王金万. 奥沙利铂治疗进展期胃癌国际临床试验研究进展 [J]. 癌症进展, 2008(6):537.
|
金梅, 李建华. 老年胃癌患者内镜所见及病理特点 [J]. 中国临床保健杂志, 2008(3):252.
|
秦叔逵, 龚新雷. 晚期胃癌化疗的现状和进展 [J]. 临床肿瘤学杂志, 2006(9):641.
|
Fukushima M. Antitumor activity and function of S-1, a new oral tegafur-based formulation [J]. Gan To Kagaku Ryoho, 2006, (Suppl 1):19.
|
Nagahama T, Ando M, Seki R. Preoperative chemotherapy for advanced gastric cancer [J]. Gan To Ka-gaku Ryoho, 2013, (12):2217.
|
Katayanagi S, Nomura T, Sumi T. The efficacy of neoadjuvant chemotherapy with S-1/CDDP (SP)to the pa-tients with large type 3 and type 4 gastric cancer [J]. Gan To Kagaku Ryoho, 2013, (12):2214.
|
Tsushima T, Hironaka S, Boku N. Safety and efficacy of s-1 monotherapy in elderly patients with avanced.gastric cancer [J]. GASTRIC CANCER, 2010(4):245.
|
Pfister D, Heidenreich A, Porres D. Biomarker docetaxel-based chemotherapy [J]. Urologe Ausgabe A, 2013(9):1261.
|
Gong J, Hu B, Zhang X. The multicenter, phase II prospective study of paclitaxel plus capecitabine as first-line chemotherapy in advanced gastric carcinoma [J]. Oncologist, 2014(2):173.
|
Xu X, Wang L, Xu H Q. Clinical comparison between paclitaxel liposome(Lipusu)and paclitaxel for treatment of patients with metastatic gastric cancer [J]. Asian Pac J Can-cer Prev, 2013(4):2591.
|
Yoneyama K, Konishi H, Yahata T. A phase Ⅱ study of paclitaxel and carboplatin with a biweekly schedule in pa-tients with epithelial ovarian cancer:Gynecologic Cancer Net-work trial [J]. Journal of Nippon Medical School, 2014(1):28.
|
仲飞, 孙国平, 顾康生. 替吉奥胶囊联合奥沙利铂加与不加紫杉醇治疗晚期胃癌的比较研究 [J]. 临床肿瘤学杂志, 2013(6):530.
|
Lee J L, Kang Y K, Kang H J. A randomised multi-centre phase Ⅱ trial of capecitabine vs.S-1 as first line treatment in elderly patients with metastatic or recarrent un-resectable gastric cancer [J]. British Journal of Cancer, 2008(4):584.
|
Jung H C, Rha S Y, Im C K. A randomized phase 2 study of docetaxel and S-1 versus docetaxel and cisplatin in advanced gastric cancer with an evaluation of SPARC expres-sion for personalized therapy [J]. CANCER, 2011, (10):2050.
|